Consolidated Statement Of Income

Perseus Proteomics Inc. - Filing #7332021

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
100,402,000 JPY
94,201,000 JPY
Cost of sales
12,717,000 JPY
7,668,000 JPY
Operating expenses
Selling, general and administrative expenses
982,415,000 JPY
784,302,000 JPY
Operating expenses
Gross profit (loss)
87,685,000 JPY
86,532,000 JPY
Ordinary profit (loss)
-879,380,000 JPY
-689,604,000 JPY
Operating profit (loss)
-894,729,000 JPY
-697,769,000 JPY
Operating expenses
Research and development expenses
616,004,000 JPY
494,494,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
46,000 JPY
55,000 JPY
Other
3,000 JPY
34,000 JPY
Non-operating income
21,111,000 JPY
8,183,000 JPY
Extraordinary income
138,000 JPY
JPY
Non-operating expenses
Other
11,000 JPY
19,000 JPY
Non-operating expenses
5,762,000 JPY
19,000 JPY
Extraordinary losses
223,290,000 JPY
95,468,000 JPY
Impairment losses
153,887,000 JPY
95,468,000 JPY
Profit (loss) before income taxes
-1,102,533,000 JPY
-785,072,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
138,000 JPY
JPY
Income taxes - current
1,927,000 JPY
1,927,000 JPY
Extraordinary losses
Income taxes
1,927,000 JPY
1,927,000 JPY
Profit (loss)
-1,104,460,000 JPY
-1,104,460,000 JPY
-1,104,460,000 JPY
-1,104,460,000 JPY
-786,999,000 JPY
-786,999,000 JPY
-786,999,000 JPY
-786,999,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.